Jun. 23, 2026
MONTPELLIER, FRANCE & BOSTON, MASS. — Cilcare announced an update to its licensing agreement with Sanofi covering its two lead programs, CIL001 and CIL003. The revised agreement includes improved royalty terms for Cilcare and will make Sanofi a minority shareholder in the company. Cilcare said the updated agreement reflects the progress and value of its lead programs and represents another
















